[Special Stock] Shinpung Pharmaceutical Rises on Research Results Showing Piramex Ingredient's COVID-19 Inhibitory Effect

[Asia Economy Reporter Park Jihwan] On the 4th, Shinpoong Pharmaceutical's stock price surged by over 4%. This is interpreted as a buying spree following news of research results showing that substances extracted from Artemisia, such as Artesunate, are effective in suppressing COVID-19. Shinpoong Pharmaceutical is repurposing Piramex, which contains Artesunate as an ingredient, as a COVID-19 treatment.

According to the Korea Exchange on the 4th, as of 10:23 AM, Shinpoong Pharmaceutical was trading at 53,000 KRW, up 4.33% (2,200 KRW) from the previous trading day.

According to major foreign media the previous day, the University of Copenhagen conducted experiments on the COVID-19 virus suppression effects of Artemisinin, Artesunate, Artemether, and Artemusua, all extracts from Artemisia. The research results concluded that all four substances are highly effective in inhibiting the coronavirus in cells.

The University of Copenhagen research team stated, "This study is the first to clearly demonstrate the possibility of developing a COVID-19 treatment based on Artemisia extracts."

This content was produced with the assistance of AI translation services.